CAMPBELL, JAMES J.,MIAO, ZHENHUA,CHARO, ISRAEL,SINGH, RAJINDER,JANSON, CHRISTINE MARIE,SCHALL, THOMAS J.,EBSWORTH, KAREN,LI, SHIJIE
申请号:
CA3075638
公开号:
CA3075638A1
申请日:
2018.09.24
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present disclosure is drawn to the combination therapy of a Chemokine Receptor 2 (CCR2) antagonist and a PD-1 and/or PD-L1 inhibitor in the treatment of cancer.